1. Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol (2020) 21:605–614. doi:10.1038/s41590-020-0677-6
2. Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus (2015) 25:727–734. doi:10.1177/0961203315627202
3. Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus (2007) 16:731–735. doi:10.1177/0961203307081113
4. Raj T, Rothamel K, Mostafavi S, Ye C, Lee MN, Replogle JM, Feng T, Lee M, Asinovski N, Frohlich I, et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes. Science (2014) 344:519–523. doi:10.1126/science.1249547
5. Jeon J-Y, Nam J-Y, Kim H-A, Park Y-B, Bae S-C, Suh C-H. Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans. Arthritis Res Ther (2014) 16:R112. doi:10.1186/ar4563
6. Al-Rayes H, Huraib G, Julkhuf S, Arfin M, Tariq M, Al-Asmari A. Apolipoprotein E Gene Polymorphisms in Saudi Patients with Systemic Lupus Erythematosus. Clin Medicine Insights Arthritis Musculoskelet Disord (2016) 9:81–87. doi:10.4137/cmamd.s38090
7. Saini RK, Keum Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance — A review. Life Sci (2018) 203:255–267. doi:10.1016/j.lfs.2018.04.049
8. Calder PC. Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Brit J Clin Pharmaco (2013) 75:645–662. doi:10.1111/j.1365-2125.2012.04374.x
9. Gutiérrez S, Svahn SL, Johansson ME. Effects of Omega-3 Fatty Acids on Immune Cells. Int J Mol Sci (2019) 20:5028. doi:10.3390/ijms20205028
10. Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases. Front Immunol (2019) 10:2241. doi:10.3389/fimmu.2019.02241
11. Halade GV, Williams PJ, Veigas JM, Barnes JL, Fernandes G. Concentrated fish oil (Lovaza®) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice. Exp Biol Med (2013) 238:610–622. doi:10.1177/1535370213489485
12. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD, et al. LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response. Cell (2008) 134:97–111. doi:10.1016/j.cell.2008.04.052
13. Sorci-Thomas MG, Thomas MJ. High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function. Arteriosclerosis Thrombosis Vasc Biology (2012) 32:2561–2565. doi:10.1161/atvbaha.112.300135
14. Ito A, Hong C, Oka K, Salazar JV, Diehl C, Witztum JL, Diaz M, Castrillo A, Bensinger SJ, Chan L, et al. Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease. Immunity (2016) 45:1311–1326. doi:10.1016/j.immuni.2016.11.008
15. Westerterp M, Gautier EL, Ganda A, Molusky MM, Wang W, Fotakis P, Wang N, Randolph GJ, D’Agati VD, Yvan-Charvet L, et al. Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. Cell Metab (2017) 25:1294-1304.e6. doi:10.1016/j.cmet.2017.04.005
16. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Díaz M, Gallardo G, et al. Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR. Immunity (2009) 31:245–258. doi:10.1016/j.immuni.2009.06.018
17. Wang B, Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol (2018) 14:452–463. doi:10.1038/s41574-018-0037-x
18. Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, Gratton E, Parks J, Tontonoz P. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife (2015) 4:e08009. doi:10.7554/elife.08009
19. Rong X, Albert CJ, Hong C, Duerr MA, Chamberlain BT, Tarling EJ, Ito A, Gao J, Wang B, Edwards PA, et al. LXRs Regulate ER Stress and Inflammation through Dynamic Modulation of Membrane Phospholipid Composition. Cell Metab (2013) 18:685–697. doi:10.1016/j.cmet.2013.10.002
20. Naoe S, Tsugawa H, Takahashi M, Ikeda K, Arita M. Characterization of Lipid Profiles after Dietary Intake of Polyunsaturated Fatty Acids Using Integrated Untargeted and Targeted Lipidomics. Metabolites (2019) 9:241. doi:10.3390/metabo9100241
21. Bertrand C, Pignalosa A, Wanecq E, Rancoule C, Batut A, Deleruyelle S, Lionetti L, Valet P, Castan-Laurell I. Effects of Dietary Eicosapentaenoic Acid (EPA) Supplementation in High-Fat Fed Mice on Lipid Metabolism and Apelin/APJ System in Skeletal Muscle. Plos One (2013) 8:e78874. doi:10.1371/journal.pone.0078874
22. Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, Terada Y, Sano S. Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus Erythematosus. Arthritis Rheumatol (2014) 66:694–706. doi:10.1002/art.38298
23. Perry D, Sang A, Yin Y, Zheng Y-Y, Morel L. Murine Models of Systemic Lupus Erythematosus. J Biomed Biotechnol (2011) 2011:271694. doi:10.1155/2011/271694
24. Alexander JJ, Jacob A, Chang A, Quigg RJ, Jarvis JN. Double negative T cells, a potential biomarker for systemic lupus erythematosus. Precis Clin Medicine (2020) 3:34–43. doi:10.1093/pcmedi/pbaa001
25. Draper E, Reynolds CM, Canavan M, Mills KH, Loscher CE, Roche HM. Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. J Nutritional Biochem (2011) 22:784–790. doi:10.1016/j.jnutbio.2010.06.009
26. Teague H, Fhaner CJ, Harris M, Duriancik DM, Reid GE, Shaikh SR. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity. J Lipid Res (2013) 54:3130–3138. doi:10.1194/jlr.m042457
27. Rockett BD, Salameh M, Carraway K, Morrison K, Shaikh SR. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J Lipid Res (2010) 51:1284–1297. doi:10.1194/jlr.m000851
28. Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Mol Immunol (2013) 56:574–582. doi:10.1016/j.molimm.2013.05.241
29. Rong X, Wang B, Palladino END, Vallim TQ de A, Ford DA, Tontonoz P. ER phospholipid composition modulates lipogenesis during feeding and in obesity. J Clin Invest (2017) 127:3640–3651. doi:10.1172/jci93616
30. Levental KR, Malmberg E, Symons JL, Fan Y-Y, Chapkin RS, Ernst R, Levental I. Lipidomic and biophysical homeostasis of mammalian membranes counteracts dietary lipid perturbations to maintain cellular fitness. Nat Commun (2020) 11:1339. doi:10.1038/s41467-020-15203-1
31. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med (2008) 14:748–755. doi:10.1038/nm1763
32. Khodadadi L, Cheng Q, Alexander T, Sercan-Alp Ö, Klotsche J, Radbruch A, Hiepe F, Hoyer BF, Taddeo A. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice. Plos One (2015) 10:e0135081. doi:10.1371/journal.pone.0135081
33. Ichikawa HT, Conley T, Muchamuel T, Jiang J, Lee S, Owen T, Barnard J, Nevarez S, Goldman BI, Kirk CJ, et al. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody‐secreting cells. Arthritis Rheumatism (2012) 64:493–503. doi:10.1002/art.33333
34. Cheng Q, Mumtaz IM, Khodadadi L, Radbruch A, Hoyer BF, Hiepe F. Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis. Ann Rheum Dis (2013) 72:2011. doi:10.1136/annrheumdis-2013-203455
35. Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fat Acids (2008) 79:101–108. doi:10.1016/j.plefa.2008.09.016
36. Rockett BD, Franklin A, Harris M, Teague H, Rockett A, Shaikh SR. Membrane Raft Organization Is More Sensitive to Disruption by (n-3) PUFA Than Nonraft Organization in EL4 and B Cells. J Nutrition (2011) 141:1041–1048. doi:10.3945/jn.111.138750
37. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol (2005) 5:230–242. doi:10.1038/nri1572
38. d’Arbonneau F, Pers J, Devauchelle V, Pennec Y, Saraux A, Youinou P. BAFF‐induced changes in B cell antigen receptor–containing lipid rafts in Sjögren’s syndrome. Arthritis Rheumatism (2006) 54:115–126. doi:10.1002/art.21478
39. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects. Cell (2010) 142:687–698. doi:10.1016/j.cell.2010.07.041
40. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature (2014) 510:92–101. doi:10.1038/nature13479
41. Ramon S, Baker SF, Sahler JM, Kim N, Feldsott EA, Serhan CN, Martínez-Sobrido L, Topham DJ, Phipps RP. The Specialized Proresolving Mediator 17-HDHA Enhances the Antibody-Mediated Immune Response against Influenza Virus: A New Class of Adjuvant? J Immunol (2014) 193:6031–6040. doi:10.4049/jimmunol.1302795
42. Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. Front Immunol (2018) 9:427. doi:10.3389/fimmu.2018.00427
43. Hirahashi J, Kawahata K, Arita M, Iwamoto R, Hishikawa K, Honda M, Hamasaki Y, Tanaka M, Okubo K, Kurosawa M, et al. Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis. Sci Rep-uk (2014) 4:6406. doi:10.1038/srep06406
44. Crevel RWR, Friend JV, Goodwin BFJ, Parish WE. High-fat diets and the immune response of C57 BI mice. Brit J Nutr (1992) 67:17–26. doi:10.1079/bjn19920005
45. Byleveld PM, Pang GT, Clancy RL, Roberts DCK. Fish Oil Feeding Delays Influenza Virus Clearance and Impairs Production of Interferon-γ and Virus-Specific Immunoglobulin A in the Lungs of Mice. J Nutrition (1999) 129:328–335. doi:10.1093/jn/129.2.328
46. Hinojosa CA, Gonzalez-Juarbe N, Rahman MM, Fernandes G, Orihuela CJ, Restrepo MI. Omega-3 fatty acids in contrast to omega-6 protect against pneumococcal pneumonia. Microb Pathogenesis (2020) 141:103979. doi:10.1016/j.micpath.2020.103979
47. Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, Cepika A-M, Acs P, Turner J, Anguiano E, et al. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell (2016) 165:551–565. doi:10.1016/j.cell.2016.03.008
48. Toro‐Domínguez D, Martorell‐Marugán J, Goldman D, Petri M, Carmona‐Sáez P, Alarcón‐Riquelme ME. Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression. Arthritis Rheumatol (2018) 70:2025–2035. doi:10.1002/art.40653
49. Golfetto O, Hinde E, Gratton E. Laurdan Fluorescence Lifetime Discriminates Cholesterol Content from Changes in Fluidity in Living Cell Membranes. Biophys J (2013) 104:1238–1247. doi:10.1016/j.bpj.2012.12.057